Mapping opioid-dependence state transitions across structural, functional, and transcriptomic topologies

Information

  • Research Project
  • 10293782
  • ApplicationId
    10293782
  • Core Project Number
    R01DA054374
  • Full Project Number
    1R01DA054374-01
  • Serial Number
    054374
  • FOA Number
    PAR-20-241
  • Sub Project Id
  • Project Start Date
    9/30/2021 - 4 years ago
  • Project End Date
    5/31/2026 - 5 months from now
  • Program Officer Name
    SATTERLEE, JOHN S
  • Budget Start Date
    9/30/2021 - 4 years ago
  • Budget End Date
    5/31/2022 - 3 years ago
  • Fiscal Year
    2021
  • Support Year
    01
  • Suffix
  • Award Notice Date
    9/23/2021 - 4 years ago

Mapping opioid-dependence state transitions across structural, functional, and transcriptomic topologies

PROJECT SUMMARY Opioid addiction is a chronic, progressive disorder that fuels the current US epidemic of opioid overdose deaths. Over the years, a tremendous amount of research effort has been devoted to understanding the biological roles of opioid receptors and developing newer generations of synthetic opioids to treat pain and combat opioid addiction. However, given the advancement of contemporary and novel neuroscience technologies, we have the tools to think beyond mu-opioid receptors (MORs) to develop improved OUD therapeutics. This proposal aims to investigate the architecture and function of endogenous MOR-expressing neural circuits in the brain and to determine how these circuits maintain cellular dependence and drive brain-wide maladaptive plasticity across different stages of the OUD cycle. In four complementary aims, we will first map the shifting structural and functional connectivity of opioidergic networks using viral-genetic and tissue clearing methods to identify monosynaptic inputs to withdrawal-active MOR-expressing cells and axonal output projections, as a function of opioid exposure and abstinence. We will then integrate these input/output maps with cell-type information and gene expression changes within dependence networks using hyper-multiplexed 3D in situ hybridizations to generate the anatomic localization of hundreds of dependence-related genes, targeted to cell types and retro- labeled connections. Finally, to reveal how MOR-expressing cells within core regions are modulated during opioid exposure in real-time, we will use miniature head-mounted microscopes to image the population activity? at cellular resolution?across weeks of opioid exposure and withdrawal. Our models will provide formal summaries of activity, connectivity, and gene expression as they evolve with repetitive opioid exposure and withdrawal, and our datasets will be made publicly available as they are generated. To bridge these experimental measurements and provide a common framework for our analyses, we will adopt Network Control Theory to identify brain nodes that drive the transition between opioid dependence states to identify potential candidates that disproportionately drive each state.

IC Name
NATIONAL INSTITUTE ON DRUG ABUSE
  • Activity
    R01
  • Administering IC
    DA
  • Application Type
    1
  • Direct Cost Amount
    388405
  • Indirect Cost Amount
    127893
  • Total Cost
    516298
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    279
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NIDA:516298\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    UNIVERSITY OF PENNSYLVANIA
  • Organization Department
    PHARMACOLOGY
  • Organization DUNS
    042250712
  • Organization City
    PHILADELPHIA
  • Organization State
    PA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    191046205
  • Organization District
    UNITED STATES